Science
FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer
The FDA has granted accelerated approval to Johnson & Johnson's Rybrevant Faspro for adults with recurrent or metastatic head and…
The FDA has granted accelerated approval to Johnson & Johnson's Rybrevant Faspro for adults with recurrent or metastatic head and…